Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer

Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer

The efficacy of chemotherapy varies significantly among patients with gastric cancer (GC), and there is currently no effective strategy to predict chemotherapeutic outcomes. In this study, we successfully establish 57 GC patient-derived organoids (PDOs) from 73 patients with GC (78%). These organoid...

Full description

Bibliographic Details
Main Authors: Zhao, Yi, Li, Shangru, Zhu, Lefan, Huang, Mingle, Xie, Yubin, Song, Xinming, Chen, Zhihui, Lau, Harry Cheuk-Hay, Sung, Joseph Jao Yiu, Xu, Lixia, Yu, Jun, Li, Xiaoxing
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Journal Article
Language:English
Published: 2024
Subjects:
Medicine, Health and Life Sciences
Chemotherapy
Gastric cancer
Online Access:https://hdl.handle.net/10356/181601

Internet

https://hdl.handle.net/10356/181601

Similar Items